Bank of America’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $641M | Buy |
1,220,359
+176,122
| +17% | +$92.5M | 0.05% | 325 |
|
|
2025
Q1 | $662M | Buy |
1,044,237
+104,039
| +11% | +$66M | 0.05% | 310 |
|
|
2024
Q4 | $670M | Sell |
940,198
-53,039
| -5% | -$37.8M | 0.06% | 289 |
|
|
2024
Q3 | $1.04B | Buy |
993,237
+25,133
| +3% | +$26.4M | 0.08% | 221 |
|
|
2024
Q2 | $1.02B | Buy |
968,104
+84,036
| +10% | +$88.3M | 0.09% | 211 |
|
|
2024
Q1 | $851M | Buy |
884,068
+5,655
| +0.6% | +$5.44M | 0.08% | 244 |
|
|
2023
Q4 | $772M | Buy |
878,413
+41,554
| +5% | +$36.5M | 0.08% | 235 |
|
|
2023
Q3 | $689M | Sell |
836,859
-1,686
| -0.2% | -$1.39M | 0.08% | 236 |
|
|
2023
Q2 | $603M | Sell |
838,545
-108,865
| -11% | -$78.2M | 0.06% | 258 |
|
|
2023
Q1 | $778M | Buy |
947,410
+53,728
| +6% | +$44.1M | 0.08% | 231 |
|
|
2022
Q4 | $645M | Sell |
893,682
-154,802
| -15% | -$112M | 0.07% | 250 |
|
|
2022
Q3 | $722M | Sell |
1,048,484
-13,820
| -1% | -$9.52M | 0.09% | 219 |
|
|
2022
Q2 | $628M | Sell |
1,062,304
-86,940
| -8% | -$51.4M | 0.07% | 248 |
|
|
2022
Q1 | $803M | Sell |
1,149,244
-12,070
| -1% | -$8.43M | 0.08% | 230 |
|
|
2021
Q4 | $733M | Buy |
1,161,314
+5,040
| +0.4% | +$3.18M | 0.07% | 245 |
|
|
2021
Q3 | $700M | Buy |
1,156,274
+40,430
| +4% | +$24.5M | 0.07% | 247 |
|
|
2021
Q2 | $623M | Sell |
1,115,844
-63,967
| -5% | -$35.7M | 0.06% | 272 |
|
|
2021
Q1 | $558M | Buy |
1,179,811
+67,688
| +6% | +$32M | 0.06% | 275 |
|
|
2020
Q4 | $537M | Sell |
1,112,123
-96,777
| -8% | -$46.8M | 0.07% | 239 |
|
|
2020
Q3 | $677M | Sell |
1,208,900
-37,221
| -3% | -$20.8M | 0.09% | 198 |
|
|
2020
Q2 | $777M | Buy |
1,246,121
+59,175
| +5% | +$36.9M | 0.12% | 166 |
|
|
2020
Q1 | $580M | Buy |
1,186,946
+57,954
| +5% | +$28.3M | 0.1% | 192 |
|
|
2019
Q4 | $424M | Buy |
1,128,992
+18,385
| +2% | +$6.9M | 0.06% | 283 |
|
|
2019
Q3 | $308M | Sell |
1,110,607
-26,961
| -2% | -$7.48M | 0.05% | 345 |
|
|
2019
Q2 | $356M | Sell |
1,137,568
-108,109
| -9% | -$33.8M | 0.05% | 309 |
|
|
2019
Q1 | $511M | Sell |
1,245,677
-2,027
| -0.2% | -$832K | 0.08% | 236 |
|
|
2018
Q4 | $466M | Buy |
1,247,704
+10,749
| +0.9% | +$4.01M | 0.08% | 227 |
|
|
2018
Q3 | $500M | Sell |
1,236,955
-63,776
| -5% | -$25.8M | 0.08% | 242 |
|
|
2018
Q2 | $449M | Buy |
1,300,731
+120,220
| +10% | +$41.5M | 0.07% | 244 |
|
|
2018
Q1 | $407M | Buy |
1,180,511
+232,256
| +24% | +$80M | 0.07% | 258 |
|
|
2017
Q4 | $357M | Sell |
948,255
-663,007
| -41% | -$249M | 0.06% | 282 |
|
|
2017
Q3 | $720M | Buy |
1,611,262
+488,243
| +43% | +$218M | 0.11% | 180 |
|
|
2017
Q2 | $552M | Buy |
1,123,019
+24,345
| +2% | +$12M | 0.11% | 182 |
|
|
2017
Q1 | $426M | Buy |
1,098,674
+103,265
| +10% | +$40M | 0.08% | 225 |
|
|
2016
Q4 | $365M | Buy |
995,409
+133,273
| +15% | +$48.9M | 0.08% | 237 |
|
|
2016
Q3 | $347M | Buy |
862,136
+221,422
| +35% | +$89M | 0.08% | 244 |
|
|
2016
Q2 | $224M | Buy |
640,714
+131,490
| +26% | +$45.9M | 0.05% | 317 |
|
|
2016
Q1 | $184M | Sell |
509,224
-141,607
| -22% | -$51M | 0.04% | 364 |
|
|
2015
Q4 | $353M | Buy |
650,831
+93,427
| +17% | +$50.7M | 0.08% | 236 |
|
|
2015
Q3 | $259M | Buy |
557,404
+121,782
| +28% | +$56.6M | 0.06% | 279 |
|
|
2015
Q2 | $222M | Buy |
435,622
+3,484
| +0.8% | +$1.78M | 0.07% | 256 |
|
|
2015
Q1 | $195M | Sell |
432,138
-26,165
| -6% | -$11.8M | 0.07% | 273 |
|
|
2014
Q4 | $188M | Sell |
458,303
-92,444
| -17% | -$37.9M | 0.07% | 285 |
|
|
2014
Q3 | $199M | Sell |
550,747
-108,724
| -16% | -$39.2M | 0.06% | 288 |
|
|
2014
Q2 | $186M | Sell |
659,471
-98,471
| -13% | -$27.8M | 0.06% | 302 |
|
|
2014
Q1 | $228M | Buy |
757,942
+21,092
| +3% | +$6.33M | 0.08% | 222 |
|
|
2013
Q4 | $203M | Buy |
736,850
+92,074
| +14% | +$25.3M | 0.07% | 241 |
|
|
2013
Q3 | $202M | Buy |
644,776
+38,761
| +6% | +$12.1M | 0.08% | 222 |
|
|
2013
Q2 | $136M | Buy |
+606,015
| New | +$136M | 0.06% | 298 |
|